{"denomUnitsSelected":"Participants","description":"Percentage of crossover was defined as percentage of patients who are able to cross-over from one arm to the other and complete at least an initial course (12 weeks) of treatment after crossover without intervening symptomatic disease progression or treatment limiting toxicity.","reportingStatus":"NOT_POSTED","timeFrame":"assessed at crossover and 12 weeks after treatment post-crossover","title":"Percentage of Crossover","type":"SECONDARY"}